Smith & Nephew
SN.: 1,156.00 -13.50 (▼1.15%)
| Bid Price | 1,155.00 | High Price | 1,167.00 |
|---|---|---|---|
| Ask Price | 1,156.00 | Low Price | 1,152.78 |
| Open Price | 1,165.00 | Spread | 0.09% |
| Prev Close | 1,169.00 | Volume | 504,875.00 |
Smith & Nephew Share Price Chart
Intraday
Historic – 1 year
Smith & Nephew Share Price Information
| Name | Smith & Nephew | Epic | SN. |
|---|---|---|---|
| Sector | Health Care Equipment & Services | ISIN | GB0009223206 |
| Activites | Smith & Nephew is an industry leader in each of its three main Global Business Units – Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges. It currently operate in 32 countries and generate annual sales of $3.8 billion. Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. This is the primary focus of its fourth business unit, Biologics. | Security Type | Equity |
Key numbers
| Latest Share Price (p) | 1,155.50 | Net Gearing (%) | 42.99 |
|---|---|---|---|
| Market Cap (£m) | 9,923.05 | Gross Gearing (%) | 44.66 |
| Shares in issue (m) | 878.15 | Debt Ratio | 31.89 |
| P/E Ratio | 24.62 | Debt-to-Equity Ratio | 0.58 |
| Divs per share (p) | 30.80 | Assets / Equity Ratio | 1.81 |
| Dividend Yield (%) | 1.78 | Price to book value | 2.50 |
| Dividend Cover | 3.11 | SROCE (%) | 9.60 |
| Earning per share (p) | 45.90 | EPS Growth (%) | -18.18 |
| 52-week high / low (p) | 1,324.00 / 1,041.00 | DPS Growth (%) | 4.05 |
Smith & Nephew Broker Views
| Date | Broker | Rec. | Price | Old target price | New target price | Notes |
|---|---|---|---|---|---|---|
| 07 Dec | Jefferies International | Buy | 1,156.00 | 1395.00 | 1370.00 | Reiterates |
| 02 Dec | Morgan Stanley | Equal weight | 1,156.00 | 1249.00 | 1249.00 | Retains |
| 02 Dec | JP Morgan Cazenove | Neutral | 1,156.00 | 1260.00 | 1260.00 | Reiterates |
| 25 Nov | Goldman Sachs | Buy | 1,156.00 | 1370.00 | 1310.00 | Reiterates |
| 07 Nov | Deutsche Bank | Hold | 1,156.00 | Retains |
Smith & Nephew Director Deals
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 31 Oct 2016 | Olivier Bohuon | Dividend Reinvestment Plan | 3449 @ 1217.65p | £41,996.75 |
| 31 Oct 2016 | Olivier Bohuon | Dividend Reinvestment Plan | 3449 @ 1217.65p | £41,996.75 |
| 16 Aug 2016 | Joseph Papa | In Lieu of Fees/Salary | 170 @ 1290.00p | £2,193.00 |
| 16 Aug 2016 | Michael Friedman | In Lieu of Fees/Salary | 231 @ 1290.00p | £2,979.90 |
| 16 Aug 2016 | Vinita Bali | In Lieu of Fees/Salary | 168 @ 1290.00p | £2,167.20 |
| 16 Aug 2016 | Ian Barlow | In Lieu of Fees/Salary | 230 @ 1290.00p | £2,967.00 |
| 16 Aug 2016 | Baroness Virginia Bottomley | In Lieu of Fees/Salary | 238 @ 1290.00p | £3,070.20 |
| 16 Aug 2016 | Erik Engstrom | In Lieu of Fees/Salary | 210 @ 1290.00p | £2,709.00 |
| 16 Aug 2016 | Robin Freestone | In Lieu of Fees/Salary | 310 @ 1290.00p | £3,999.00 |
| 16 Aug 2016 | Brian Larcombe | In Lieu of Fees/Salary | 210 @ 1290.00p | £2,709.00 |
| 16 Aug 2016 | Roberto Quarta | In Lieu of Fees/Salary | 4391 @ 1290.00p | £56,643.90 |
Smith & Nephew Company News
Broker Forecast – Jefferies International issues a broker note on Smith & Nephew PLC
Jefferies International today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1370p (from 1395p).
Story provided by StockMarketWire.com
Smith & Nephew appoints Graham Baker as CFO
Smith & Nephew announces the appointment of Graham Baker as Chief Financial Officer. He will formally begin the role on 1 March 2017 when he will also be appointed to the Board as an Executive Director.
Story provided by StockMarketWire.com
FLASH: Smith & Nephew appoints Graham Baker as CFO
Story provided by StockMarketWire.com
Broker Forecast – Goldman Sachs issues a broker note on Smith & Nephew PLC
Goldman Sachs today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1310p (from 1370p).
Story provided by StockMarketWire.com
Broker Forecast – Jefferies International issues a broker note on Smith & Nephew PLC
Jefferies International today reaffirms its buy investment rating on Smith & Nephew PLC (LON:SN.) and cut its price target to 1395p (from 1420p).
Story provided by StockMarketWire.com
